share_log

Agilon Health, Inc.'s (NYSE:AGL) Profit Outlook

Agilon Health, Inc.'s (NYSE:AGL) Profit Outlook

Agilon Health, Inc.”s(紐約證券交易所代碼:AGL)利潤展望
Simply Wall St ·  01/14 08:48

With the business potentially at an important milestone, we thought we'd take a closer look at agilon health, inc.'s (NYSE:AGL) future prospects. agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. With the latest financial year loss of US$107m and a trailing-twelve-month loss of US$89m, the US$3.0b market-cap company alleviated its loss by moving closer towards its target of breakeven. Many investors are wondering about the rate at which agilon health will turn a profit, with the big question being "when will the company breakeven?" In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.

由於該業務可能處於重要的里程碑,我們認爲應該仔細研究一下agilon Health, inc.”s(紐約證券交易所代碼:AGL)的未來前景。agilon Health, inc.通過美國社區的初級保健醫生爲老年人提供醫療保健服務。這家市值30億美元的公司最近一個財年的虧損爲1.07億美元,過去十二個月的虧損爲8900萬美元,通過接近盈虧平衡的目標來緩解虧損。許多投資者想知道agilon Health的盈利速度,最大的問題是 “公司何時會實現盈虧平衡?”在本文中,我們將介紹對公司增長的預期以及分析師預計何時實現盈利。

View our latest analysis for agilon health

查看我們對 agilon Health 的最新分析

agilon health is bordering on breakeven, according to the 14 American Healthcare analysts. They expect the company to post a final loss in 2024, before turning a profit of US$46m in 2025. The company is therefore projected to breakeven just over a year from today. How fast will the company have to grow each year in order to reach the breakeven point by 2025? Working backwards from analyst estimates, it turns out that they expect the company to grow 57% year-on-year, on average, which is extremely buoyant. Should the business grow at a slower rate, it will become profitable at a later date than expected.

根據14位美國醫療分析師的說法,agilon Health接近盈虧平衡。他們預計,該公司將在2024年公佈最終虧損,然後在2025年實現4600萬美元的盈利。因此,預計從今天起一年多之後,該公司將實現盈虧平衡。爲了到2025年達到盈虧平衡點,公司每年必須以多快的速度增長?從分析師的估計來看,事實證明,他們預計該公司的平均同比增長57%,這是非常活躍的。如果業務增長速度放緩,則盈利的時間將比預期的晚。

earnings-per-share-growth
NYSE:AGL Earnings Per Share Growth January 14th 2024
紐約證券交易所:AGL 每股收益增長 2024 年 1 月 14 日

Underlying developments driving agilon health's growth isn't the focus of this broad overview, though, take into account that generally a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

但是,推動agilon Health增長的潛在發展並不是本次廣泛概述的重點,但要考慮到高增長率通常並非不尋常,尤其是在公司處於投資期時。

Before we wrap up, there's one aspect worth mentioning. The company has managed its capital prudently, with debt making up 4.6% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.

在我們總結之前,有一個方面值得一提。該公司謹慎地管理了資本,債務佔股權的4.6%。這意味着其運營資金主要來自股權資本,其低債務債務降低了投資這家虧損公司的風險。

Next Steps:

後續步驟:

There are key fundamentals of agilon health which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at agilon health, take a look at agilon health's company page on Simply Wall St. We've also compiled a list of essential factors you should further examine:

本文未涵蓋敏捷健康的關鍵基礎知識,但我們必須再次強調,這只是一個基本的概述。要更全面地了解agilon Health,請查看 Agilon Health 在 Simply Wall St 上的公司頁面。我們還整理了一份你應該進一步研究的基本因素清單:

  1. Valuation: What is agilon health worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether agilon health is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on agilon health's board and the CEO's background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
  1. 估值:今天的Agilon Health值多少錢?價格中是否已經考慮了未來的增長潛力?我們的免費研究報告中的內在價值信息圖有助於可視化agilon Health目前是否被市場錯誤定價。
  2. 管理團隊:一支經驗豐富的管理團隊掌舵增強了我們對業務的信心——看看誰是agilon Health董事會成員以及首席執行官的背景。
  3. 其他表現優異的股票:還有其他股票可以提供更好的前景並有良好的往績記錄嗎?在這裏瀏覽我們免費列出的這些優質股票。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論